Dean Michael Cooper

age:

52 years

appointments:

22 active

15 prior

primary industry:

Manufacture of basic pharmaceutical products and pharmaceutical preparations

about Dean

Since 2018, Mr Cooper has been a director of 37 companies, the current directorship have a combined turnover of approximately £15m.

Combined Valuation

£3.3b

Combined Turnover

£15m

active directorships over time

company
turnover
valuation
start
end
status
role
teva acquisition limited-£895.7mJul 2018-OpenDirector
actavis holdings uk ii limited-£710.6mJul 2018-OpenDirector
actavis uk group limited-£529mJul 2018-OpenDirector
actavis holdings uk ltd.-£517.8mJul 2018-OpenDirector
teva milbrook holdings limited-£279.9mJul 2018-OpenDirector
teva ni limited£11.4m£217.6mJul 2021-OpenDirector
auden mckenzie (pharma division) limited£3.4m£151.8mJul 2018-OpenDirector
nrim limited-£11.2mJul 2018-OpenDirector
pliva pharma limited-£10.4mJul 2018-OpenDirector
teva pharmaceuticals limited-£9.9mJul 2018-OpenDirector
breath limited£193k£5.2mJul 2018-OpenDirector
lime pharma limited-£4.8mJul 2018-OpenDirector
auden mckenzie holdings limited-£525.5kJul 2018-OpenDirector
arrow generics limited-£18.7kJul 2018-OpenDirector
cephalon (uk) limited-£6.7Jul 2018-OpenDirector
teva pharma uk limited-£2Jul 2018-OpenDirector
teva uk holdco 1 limited-£0Sep 2019-OpenDirector
bowmed limited--Jul 2018-OpenDirector
orvet uk--Jul 2018-OpenDirector
arrow no 7 limited--Jul 2018-OpenDirector
teva uk holdco 3 limited--Sep 2019-OpenDirector
teva uk holdco 2 limited--Sep 2019-OpenDirector